Aufklappen
Schliessen
- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten |
|---|---|
| Di | Janssen's guselkumab shows long-term benefit in psoriasis |
| Di | Teva sells off women's health assets for $1.38bn |
| Di | GSK, Innoviva announce US nod for Trelegy Ellipta |
| Di | AbbVie/Roche's venetoclax hits goals in CLL trial |
| Mo | CHMP backs 13 treatments for EU approval |
| Mo | Bavarian Nordic hit by cancer immunotherapy failure |
| Mo | Bayer's rare cancer drug Aliqopa bags speedy approval |
| Mo | NICE rejects first-line use of Roche's Gazyvaro |
| Fr | Marketer & Communications Team of the Year - venue announced! |
| Fr | Five firms named in breaches of ABPI code |
| Fr | Most HCPs not aware of Accelerated Access Review - report |
| Fr | FDA approves first cancer biosimilar |
| Do | Number of written complaints about NHS increases 4.9 per cent |
| Do | Cardiovascular outcomes dominate EASD |
| Do | AstraZeneca to divest remaining anaesthetics portfolio rights |
| 13.09. | Abbott's flash glucose monitor to be made available on NHS |
| 13.09. | FDA grants fast-track designation for Shire's lung drug |
| 13.09. | ESMO news - 13 September |
| 12.09. | Teva names Lundbeck's Kåre Schultz as President and Chief Executive Officer |
| 12.09. | Humira gets EC approval for anterior uveitis |
| 12.09. | Conference round-up: ERS and ESMO |
| 12.09. | Prix Galien opens for entries with new award |
| 12.09. | SMC accepts 4 new medicines |
| 11.09. | Cushman & Wakefield Appoints London healthcare specialist |
| 11.09. | New migraine results for both Allergen and Novartis |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von